Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

3selected
Comparing 3 of 3 drugs
× × ×
Change selection
3 drug columns · use arrows or scrollbar
Field FRUSEMIDE
Renal · Renal · Level 1
HYDROCHLOROTHIAZIDE
Renal · Renal · Level 3
SPIRONOLACTONE
Renal · Renal · Level 3
Mechanism of action

Diuresis
Inhibition of active chloride ion reabsorption in PCT and ascending limb of LoH
↓ reabsorption of NaCl → ↓ tonicity in the renal medulla → ↓water reabsorption and diuresis.
Other effects are mediated by the induction of the COX-2 enzyme which assists in synthesis of prostaglandins.

inhibit Na+ reabsorption in the early portion of the distal tubule by
blocking the Na+.Cl- symporter in the apical membrane of these cells. Naturesis
occurs with thiazide diuretics is 5-10% of the filtered load

Acts in the DCT.
It is a competitive antagonist of aldosterone at the receptors in the DCT.
Decreased Na reabsorption and increased K reabsorption
= Increased Na loss and Diuresis.

Physiological effects

Pulmonary and systemic vasodilation
Diuresis ↑ RBF and ↑ corticomedullary blood flow
↓O₂ demand in the LoH (ischaemic
protection)

Anti-HTN: (↓TPR, ↓plasma volume)
↓RBF → ↓GFR
↓K+,Na+,Mg.
Hyperchloremic MA
↑Ca++ (↓excretion)
↑Glu: (↓glycogenolysis, ↓insulin)

Sedation and muscle weakness (due to electrolyte abnm)
Antihypertensive,
Diuresis (in 3-4 days)
Potassium retention
Anti-androgenic effect- inhbn of ovarian androgen secretion
↑renal Ca excr, ↑plasma urea
Reversible hyperchloraemic MA

Absorption

PO/IV/SL/IM. PO BA 50% Onset PO/SL 30-60mins, IV 5 mins .
Dur PO/SL 6-8hrs, IV 2hrs

PO- BA ~50-80%. Onset 2hrs Dur 6-12hrs.

PO - BA 70%, extensive 1st pass metb. Onset 3-4hrs, dur upto 3 days

Protein binding

91-99% (Albumin)

68%

90%

Volume of distribution

0.1L/kg

3.6-7.8L/kg

—
Metabolism

Renal to glucuronide
Minimal hepatic

Not metabolized

Hepatic: Rapidly and extensively metabolised by deacetylation and dethiolation. Active metab: canrenone and 7-alpha-spirolactone

Excretion

80% unchanged in urine

Urine (unchanged)

Urine and faeces

Half-life

0.5-2hrs. ESRF: 9hrs

5.6-14.8hrs

1-2hours, metab upto 24hrs

Adverse Effects Toxicity

↓ K+/Na+/Cl-/Ca++, Hyper- urea/glu/chol, Metabolic alkalosis
Tox: Deafness, Pancreatitis
BM depression
Interstitial nephritis (worse with aminoglycoside)

↓K+/Na+/Mg++, ↑Ca++/urea/glu/chol.
indiosyncratic blood
dyscrasias. Rash, photsensitivity. Interactions may prolong action of NDMBs. NSAIDs antagonise the action

↑K+(esp in renal failure). N/V and GI disturbances
Menstr irreg, Gynaecomastia
↑digoxin conc.
↓pressor response
↑effects of CVS depressants

Class Group

Diuretic - Loop

Diuretic - Thiazide

Diuretic – Aldosterone antagonist

Indications Uses

Oedema of cardiac, renal or hepatic origin, Renal insufficency
Hypertension
Raised ICP
Hypercalcaemia

heart failure and hypertension. Used in combination. mostly bound to plasma prot, and gain access to the tubule via secretion in the PCT.

Oedema – CHF, cirrhosis with ascites, refractory. HTN, Nephrotic syndrome. With loop/thiazide to conserve K+, diagn of Conn's syndr

Introduction

Sulfonamide derivative

related to the sulphonamides

A synthetic steroid

Legacy Cicm Level

Level 1

Level 3

Level 3

Presentation

Photosensitive solution 10mg/ml
20/40/500mg tabs, Syrup

orange scored tablets of 25mg and combos

25/100mg tablets

Route And Dose

20-2000mg daily
PO/IV/SL/IM.

PO. 12.5-200mg/day

PO. 25-200mg/day